Vanda Pharmaceuticals (VNDA) Other financing activities (2010 - 2022)
Vanda Pharmaceuticals (VNDA) posted Other financing activities of $571000.0 for Q4 2022, up 14175.0% sequentially from $4000.0 in Q3 2022, and down 47.66% YoY from $1.1 million in Q4 2021.
Vanda Pharmaceuticals (VNDA) Other financing activities (2010 - 2022) Analysis & Trends
Vanda Pharmaceuticals has reported Other financing activities for 10 years, with the latest figure at $571000.0 in Q4 2022.
- Quarterly Other financing activities fell 47.66% year-over-year to $571000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2023 was $575000.0 (down 17.86% YoY) and the FY2022 annual result came in at $700000.0, down 80.56% from the prior year.
- Other financing activities climbed to $571000.0 in Q4 2022 per VNDA's latest filing, from $4000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $3.6 million in Q2 2020 and troughed at $4000.0 in Q3 2022.
- A 5-year average of $1.2 million and a median of $571000.0 in 2022 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2018 and 2022: Other financing activities soared 481.54% in 2018, then sank 98.92% in 2022.
- Over 5 years, Other financing activities stood at $756000.0 in 2018, then jumped by 184.66% to $2.2 million in 2019, then plunged by 33.46% to $1.4 million in 2020, then fell by 23.81% to $1.1 million in 2021, then tumbled by 47.66% to $571000.0 in 2022.
- According to Business Quant data, Other financing activities over the past three periods registered $571000.0, $4000.0, and $125000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vanda Pharmaceuticals | 315.57 Mn | 145.54 Mn | 46.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 571,000.00 |
| Dec 31, 2022 | 571,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 125,000.00 |
| Jun 30, 2022 | 125,000.00 |
| Dec 31, 2021 | 1.09 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 371,000.00 |
| Sep 30, 2021 | 371,000.00 |
| Jun 30, 2021 | 338,000.00 |
| Jun 30, 2021 | 338,000.00 |
| Mar 31, 2021 | 1.80 Mn |
| Mar 31, 2021 | 1.80 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Sep 30, 2020 | 102,000.00 |
| Sep 30, 2020 | 102,000.00 |
| Jun 30, 2020 | 3.60 Mn |
| Jun 30, 2020 | 3.60 Mn |